Skip to content

CFUnite’s Virtual Presentation On Vertex Pharmaceuticals’ Orphan Drug Kalydeco (Ivacaftor)

January 17, 2013

CFUnite (Cystic Fibrosis Unite), had a virtual online event on Vertex Pharmaceuticals’ orphan drug Kalydeco (Ivacaftor) and the Cystic Fibrosis Transmembrane Regulator (CFTR) protein, on January 12, 2013.

CFUnite has 5 videos available on their website for those who weren’t able to participate in this event this past weekend. The videos are on the following topics :

–  Video #1 – Introduction to the event

–  Video #2 – Dr. David Sheppard, University of Bristol, discusses the Cystic Fibrosis Transmembrane Regulator (CFTR) protein that affects Cystic Fibrosis (CF)

–  Video #3 – Professor Stuart Elborn CBE, Queens University, Belfast, presents Phase III clinical trial results of Kalydeco for CF patients with G551D mutation

Video #4 – Dr. Michael Boyle, John Hopkins University, Baltimore USA, presents Phase II clinical trial results of Kalydeco + VX-809 given to CF patients with dF508

Video #5 –  Ed Owen, CEO of CF Trust UK – Discussion of what it is like for a patient to have CF and to take Kalydeco. Also, the “power of a united community of people with CF” is discussed.

References

Vertex Pharmaceuticals 4th Quarter 2012 & Year End Financial Results Conference Call – January 29, 2013, 5:00 PM ET.

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: